The new treatment, which is a compound of antibiotics and pirfenidone, helps the healing of diabetes patients affected with diabetic foot ulcers, even those with non-healing chronic diabetic ulcers," said Dr. Pedro Peña Santoyo., one of the lead doctors in charge of developing Kitocell-Q.
The treatment was first used on a patient who had come into hospital with an extremely advanced foot infection that had already affected his skin, muscles, nerves and tendons; in fact, he was coming in to have his lower leg amputated. As a last-ditch effort at recovery, doctors decided to treat him with Kitocell-Q and, reportedly, within a week he had recovered to the point where amputation was no longer necessary.
Although the treatment has shown success in even very severe cases such as this one, developers are quick to point out that it is not a miracle treatment—if an infection reaches your bone, Kitocell-Q cannot provide a remedy and it is very likely that an amputation will be necessary.
There is no word yet on when or if Kitocell-Q will be available in the United States but, of course, we have plenty of other products that treat wounds and ulcers. It’s important to keep in mind, however, that the best way to prevent amputation is to take proactive steps to protect your foot health—engage in daily foot checks to discover minor wounds before they turn into major problems, keep your feet clean, dry and moisturized and stay on top of regular visits with your Houston podiatrist so that last-resort cures will never be a necessity.